A novel glucokinase activator TMG-123 causes long-lasting hypoglycemia and impairs spermatogenesis irreversibly in rats
- 1 January 2021
- journal article
- research article
- Published by Japanese Society of Toxicology in The Journal of Toxicological Sciences
- Vol. 46 (3), 115-123
- https://doi.org/10.2131/jts.46.115
Abstract
The importance of glucose is well known as an energy source in testes. In order to evaluate the effects of long-lasting hypoglycemia on testes, a novel glucokinase activator, TMG-123, was dosed to rats at 5, 20 and 100 mg/kg for 13 weeks. As a result, plasma glucose levels decreased for several hours with increasing doses over the dose range of 5 to 100 mg/kg. No toxicological findings attributable to the test article were observed in clinical observation, measurements of body weight and food consumption, necropsy, and organ weight measurement. Histopathology showed scattered degeneration of seminiferous tubules in testes, and exfoliation of germ cells related to the degeneration of seminiferous tubules was observed in the lumen of both epididymides in the same animals at the end of the dosing period. Similar histopathological findings were noted at the end of the recovery period. In addition, a fertility study was conducted at the same doses for 13 weeks for males and 5 weeks for females. Sperm analysis showed decreases in the sperm concentration and the motility index and an increase in the incidences of sperm malformations. However, there were no abnormalities in the copulation or fertility rate. These results suggest that long-lasting hypoglycemia in rats is harmful to spermatogenesis and the testicular damage does not recover.Keywords
This publication has 10 references indexed in Scilit:
- TMG-123, a novel glucokinase activator, exerts durable effects on hyperglycemia without increasing triglyceride in diabetic animal modelsPLOS ONE, 2017
- Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of DiabetesDiabetologia, 2016
- Metabolic regulation is important for spermatogenesisNature Reviews Urology, 2012
- Liver glucokinase: An overview on the regulatorymechanisms of its activityIUBMB Life, 2011
- The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD studyBMJ, 2010
- Assessing the potential of glucokinase activators in diabetes therapyNature Reviews Drug Discovery, 2009
- Effects of Chemotherapeutic Agents for Testicular Cancer on the Male Rat Reproductive System, Spermatozoa, and FertilityJournal of Andrology, 2006
- A Novel Glucokinase Activator Modulates Pancreatic Islet and Hepatocyte FunctionEndocrinology, 2005
- Lactate and energy metabolism in male germ cellsTrends in Endocrinology & Metabolism, 2004
- HEXOKINASESErgebnisse der Physiologie, 1994